This article previews a research story about a targeted antibody-based delivery method to reprogram brain support cells into neurons, framing its potential and challenges. Readers will get an accessible look at a novel therapeutic strategy for neuroregeneration and how it might fit into Alzheimer's research.
Key Takeaways
- At the very least there are far fewer practical options for delivery
- While direct injection into the brain or into reservoirs of cerebrospinal fluid can be achieved
- Brain is made up of many different cell types